ConvaTec names interim chief executive Paul Moraviec as its permanent CEO.
ConvaTec, which is rumored to be exploring a sale, said yesterday that it made its interim CEO, former EMEA president Paul Moraviec, to be its new permanent CEO.
Luxembourg-based ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, tapped Moraviec to lead its business in Europe, the Middle East and Africa in 2009.
Teleflex expands a Class I recall for Maquet Servo 163 humidifiers and beats expectations with its 4th-quarter earnings on the strength of 45% profit growth.
Teleflex enters a 3-year agreement with group purchasing organization Premier for its Arrow dialysis access products.
Teleflex says it won a grant from the U.S. Army worth more than $2 million to develop an anti-microbial orthopedic device using Teleflex's Semprus Sustain coating technology.
Teleflex (NYSE:TFX) said today that it landed a U.S. Army grant for the Semprus Sustain anti-microbial coating technology it was having a hard time with earlier this year.
Teleflex issues a Class I recall of its pediatric anesthesia devices over concerns that certain components could break during use, resulting in serious injury or even death.
Teleflex reportedly plans an expansion of its catheter production operations in the Czech Republic.
Teleflex (NYSE:TFX) reportedly plans to expand its catheter production operations in the Czech Republic, where it already has some 700 employees.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M